BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17521199)

  • 1. A novel crystallization-induced diastereomeric transformation based on a reversible carbon-sulfur bond formation. Application to the synthesis of a gamma-secretase inhibitor.
    Davies AJ; Scott JP; Bishop BC; Brands KM; Brewer SE; Dasilva JO; Dormer PG; Dolling UH; Gibb AD; Hammond DC; Lieberman DR; Palucki M; Payack JF
    J Org Chem; 2007 Jun; 72(13):4864-71. PubMed ID: 17521199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical asymmetric synthesis of a gamma-secretase inhibitor exploiting substrate-controlled intramolecular nitrile oxide-olefin cycloaddition.
    Scott JP; Oliver SF; Brands KM; Brewer SE; Davies AJ; Gibb AD; Hands D; Keen SP; Sheen FJ; Reamer RA; Wilson RD; Dolling UH
    J Org Chem; 2006 Apr; 71(8):3086-92. PubMed ID: 16599604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical synthesis of a gamma-secretase inhibitor.
    Scott JP; Lieberman DR; Beureux OM; Brands KM; Davies AJ; Gibson AW; Hammond DC; McWilliams CJ; Stewart GW; Wilson RD; Dolling UH
    J Org Chem; 2007 May; 72(11):4149-55. PubMed ID: 17465573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline gamma-secretase inhibitors.
    Truong AP; Aubele DL; Probst GD; Neitzel ML; Semko CM; Bowers S; Dressen D; Hom RK; Konradi AW; Sham HL; Garofalo AW; Keim PS; Wu J; Dappen MS; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Hemphill SS; Bova MP; Bard F; Yednock TA; Basi G
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4920-3. PubMed ID: 19660943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of BACE-1 inhibitors utilizing a tertiary hydroxyl motif as the transition state mimic.
    Wångsell F; Russo F; Sävmarker J; Rosenquist A; Samuelsson B; Larhed M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4711-4. PubMed ID: 19576765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted 2-oxo-azepane derivatives are potent, orally active gamma-secretase inhibitors.
    Kitas EA; Galley G; Jakob-Roetne R; Flohr A; Wostl W; Mauser H; Alker AM; Czech C; Ozmen L; David-Pierson P; Reinhardt D; Jacobsen H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):304-8. PubMed ID: 17983746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative biaryl coupling of thiophenes and thiazoles with arylboronic acids through palladium catalysis: otherwise difficult C4-selective C-H arylation enabled by boronic acids.
    Kirchberg S; Tani S; Ueda K; Yamaguchi J; Studer A; Itami K
    Angew Chem Int Ed Engl; 2011 Mar; 50(10):2387-91. PubMed ID: 21351361
    [No Abstract]   [Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase.
    Zhu Y; Xiao K; Ma L; Xiong B; Fu Y; Yu H; Wang W; Wang X; Hu D; Peng H; Li J; Gong Q; Chai Q; Tang X; Zhang H; Li J; Shen J
    Bioorg Med Chem; 2009 Feb; 17(4):1600-13. PubMed ID: 19162488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,6-Disubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors.
    Pissarnitski DA; Asberom T; Bara TA; Buevich AV; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; McEwan M; McKittrick BA; Nechuta TL; Parker EM; Sinning L; Smith EM; Song L; Vaccaro HA; Voigt JH; Zhang L; Zhang Q; Zhao Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):57-62. PubMed ID: 17055268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of potent inhibitors of human beta-secretase. Part 2.
    Freskos JN; Fobian YM; Benson TE; Moon JB; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):78-81. PubMed ID: 17049233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrocyclic inhibitors of beta-secretase: functional activity in an animal model.
    Stachel SJ; Coburn CA; Sankaranarayanan S; Price EA; Wu G; Crouthamel M; Pietrak BL; Huang Q; Lineberger J; Espeseth AS; Jin L; Ellis J; Holloway MK; Munshi S; Allison T; Hazuda D; Simon AJ; Graham SL; Vacca JP
    J Med Chem; 2006 Oct; 49(21):6147-50. PubMed ID: 17034118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting.
    Rajendran L; Schneider A; Schlechtingen G; Weidlich S; Ries J; Braxmeier T; Schwille P; Schulz JB; Schroeder C; Simons M; Jennings G; Knölker HJ; Simons K
    Science; 2008 Apr; 320(5875):520-3. PubMed ID: 18436784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydroquinoline sulfonamides as gamma-secretase inhibitors.
    Asberom T; Bara TA; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; Parker EM; Pissarnitski DA; Song L; Zhang L; Zhao Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):205-7. PubMed ID: 17046254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and SAR of hydroxyethylamine based phenylcarboxyamides as inhibitors of BACE.
    Wu YJ; Zhang Y; Good AC; Burton CR; Toyn JH; Albright CF; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2009 May; 19(10):2654-60. PubMed ID: 19375914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conformational constraint improves a beta-secretase inhibitor but for an unexpected reason.
    Hills ID; Holloway MK; de León P; Nomland A; Zhu H; Rajapakse H; Allison TJ; Munshi SK; Colussi D; Pietrak BL; Toolan D; Haugabook SJ; Graham SL; Stachel SJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4993-5. PubMed ID: 19640712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
    Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretase.
    Bergstrom CP; Sloan CP; Wang HH; Parker MF; Smith DW; Zheng M; Hansel SB; Polson CT; Barber LE; Bursuker I; Guss VL; Corsa JA; Barten DM; Felsenstein KM; Roberts SB
    Bioorg Med Chem Lett; 2008 Jan; 18(1):175-8. PubMed ID: 18023581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design and synthesis of potent dibenzazepine motifs as beta-secretase inhibitors.
    Al-Tel TH; Al-Qawasmeh RA; Schmidt MF; Al-Aboudi A; Rao SN; Sabri SS; Voelter W
    J Med Chem; 2009 Oct; 52(20):6484-8. PubMed ID: 19788239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.
    Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.